FGSN · Insider Trading
F&G Annuities & Life, Inc. 7.300% Junior Subordinated Notes due 2065
Every open-market purchase and sale reported by FGSN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-03 | Michael Joseph Nolan | Director | A | +1,067 | — |
| 2026-04-03 | Michael L Gravelle | EVP, General Counsel & Corp S | F | −855 | −$20.76K |
| 2026-04-03 | Conor Murphy | President and CFO | F | −10,566 | −$272.50K |
| 2026-04-03 | Douglas K Ammerman | Director | A | +863 | — |
| 2026-04-03 | Raymond R Quirk | Director | A | +1,067 | — |
| 2026-03-13 | Celina J. Wang Doka | Director | Buy | +4,760 | +$99.86K |
| 2026-03-13 | Christopher O Blunt | Chief Executive Officer | Buy | +10,000 | +$209.90K |
| 2026-03-03 | Wendy J.B. Young | EVP, CLO & Treasurer | F | −4,142 | −$93.82K |
| 2026-03-03 | Christopher O Blunt | Chief Executive Officer | F | −20,846 | −$472.16K |
| 2026-03-03 | William P Foley II | Executive Chairman | F | −12,318 | −$279.00K |
| 2026-01-07 | Raymond R Quirk | Director | MIXED | +133,420 | +$4.09M |
| 2026-01-07 | Michael Joseph Nolan | Director | MIXED | +21,888 | +$646.21K |
| 2026-01-07 | Douglas K Ammerman | Director | MIXED | +9,059 | +$255.99K |
| 2026-01-02 | Christopher O Blunt | Chief Executive Officer | MIXED | +10,473 | +$316.64K |
| 2025-12-31 | Fidelity National Financial, Inc. | 10%+ Owner | J | −16,280,204 | — |
| 2025-12-03 | Christopher O Blunt | Chief Executive Officer | F | −39,588 | −$1.29M |
| 2025-12-03 | Wendy J.B. Young | EVP, CLO & Treasurer | F | −6,934 | −$226.46K |
| 2025-12-03 | William P Foley II | Executive Chairman | F | −54,152 | −$1.77M |
| 2025-12-03 | John David Currier Jr. | EVP, Senior Advisor | F | −5,609 | −$183.19K |
| 2025-12-03 | Leena Punjabi | EVP, Chief Investment Officer | F | −2,343 | −$76.52K |
| 2025-11-19 | Christopher O Blunt | Chief Executive Officer | Buy | +5,000 | +$149.40K |
| 2025-11-18 | Wendy J.B. Young | EVP, CLO & Treasurer | F | −5,037 | −$163.50K |
| 2025-11-18 | Leena Punjabi | EVP, Chief Investment Officer | F | −2,724 | −$88.42K |
| 2025-11-18 | William P Foley II | Executive Chairman | F | −20,995 | −$681.50K |
| 2025-11-18 | John David Currier Jr. | EVP, Senior Advisor | F | −4,074 | −$132.24K |
| 2025-11-18 | Christopher O Blunt | Chief Executive Officer | F | −28,335 | −$919.75K |
| 2025-11-13 | Michael L Gravelle | EVP, General Counsel & Corp S | A | +9,194 | — |
| 2025-11-13 | Douglas Martinez | Director | A | +6,436 | — |
| 2025-11-13 | Douglas K Ammerman | Director | A | +6,436 | — |
| 2025-11-13 | Conor Murphy | President and CFO | A | +122,587 | — |
| 2025-11-13 | Michael Joseph Nolan | Director | A | +6,436 | — |
| 2025-11-13 | Celina J. Wang Doka | Director | A | +6,436 | — |
| 2025-11-13 | Christopher O Blunt | Chief Executive Officer | A | +260,497 | — |
| 2025-11-13 | William P Foley II | Executive Chairman | A | +199,204 | — |
| 2025-11-13 | John D Rood | Director | A | +6,436 | — |
| 2025-11-13 | Leena Punjabi | EVP, Chief Investment Officer | A | +21,913 | — |
| 2025-11-13 | Wendy J.B. Young | EVP, CLO & Treasurer | A | +38,769 | — |
| 2025-11-13 | Raymond R Quirk | Director | A | +6,436 | — |
| 2025-10-03 | Douglas K Ammerman | Director | A | +722 | — |
| 2025-10-03 | Michael Joseph Nolan | Director | A | +892 | — |
| 2025-10-03 | Raymond R Quirk | Director | A | +892 | — |
| 2025-09-19 | Leena Punjabi | EVP, Chief Investment Officer | Sell | −3,000 | −$101.43K |
| 2025-09-02 | Christopher O Blunt | Chief Executive Officer | Buy | +7,000 | +$238.15K |
| 2025-07-02 | Michael Joseph Nolan | Director | A | +845 | — |
| 2025-07-02 | Douglas K Ammerman | Director | A | +684 | — |
| 2025-07-02 | Raymond R Quirk | Director | A | +845 | — |
| 2025-05-19 | Christopher O Blunt | Chief Executive Officer | Buy | +6,000 | +$191.28K |
| 2025-05-16 | Christopher O Blunt | Chief Executive Officer | Buy | +5,000 | +$160.55K |
| 2025-05-15 | Christopher O Blunt | Chief Executive Officer | Buy | +15,000 | +$461.70K |
| 2025-05-12 | Christopher O Blunt | Chief Executive Officer | Buy | +15,000 | +$469.65K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Fidelity National Financial, Inc. | 10%+ Owner | 94,293,471 | $1.78B |
| Christopher O Blunt | Chief Executive Officer | 1,107,128 | $20.92M |
| William P Foley II | Executive Chairman | 839,614 | $15.87M |
| Raymond R Quirk | Director | 311,489 | $5.89M |
| Conor Murphy | President and CFO | 195,212 | $3.69M |
| Wendy J.B. Young | EVP, CLO & Treasurer | 105,154 | $1.99M |
| Leena Punjabi | EVP, Chief Investment Officer | 80,910 | $1.53M |
| Michael Joseph Nolan | Director | 80,746 | $1.53M |
| John David Currier Jr. | EVP, Senior Advisor | 78,518 | $1.48M |
| Douglas K Ammerman | Director | 64,086 | $1.21M |
| Michael L Gravelle | EVP, General Counsel & Corp S | 52,756 | $997.09K |
| John D Rood | Director | 43,009 | $812.87K |
| Celina J. Wang Doka | Director | 32,070 | $606.14K |
| Douglas Martinez | Director | 26,532 | $501.45K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FGSN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.